Feature
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
HebaBiz Biotech Obtains FDA Clearance to Trial Cancer Drug Against Aggressive Brain Tumor
2021-08-22
China’s Abogen Raises $700M to Fund the First Homegrown mRNA COVID-19 Vaccine to Enter Human Trial
2021-08-20
ExeVir Bio’s COVID-19 Neutralizing Antibody Derived From Llamas Advances to Phase 1 Trials
2021-08-19
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03